en.wikipedia.org website review
Improve your SEO :: free trial!
en.wikipedia.org is 54% geoptimaliseerd!
SEO Keyword summary for en.wikipedia.org/wiki/filgotinib
Keywords are extracted from the main content of your website and are the primary indicator of the words this page could rank for. By frequenty count we expect your focus keyword to be filgotinib
Focus keyword
Short and long tail
Short Tail Keywords filgotinib with trial |
long Tail Keywords (2 words) rheumatoid arthritis clinical trial press release darwin 1 trial number |
long Tail Keywords (3 words) clinical trial number active rheumatoid arthritis rheumatoid arthritis patients 27 july 2020 26 february 2015 moderate to severe clinicaltrialsgov clinical trial |
en.wikipedia.org On-Page SEO Scan
Descriptive Elements
The <head> element of a en.wikipedia.org/wiki/filgotinib page is used to inform the browser and visitors of the page about the general meta information. The head section of the page is where we place the page title, the definition of the HTML version used, the language of in which the page is written. In the head section we can also include JavaScript and CSS (markup) files for the page.
Page title
Title length
filgotinib wikipedia
Meta description
Meta description legth
Meta description SEO
No meta relevance in the description detected !
Content SEO
Number of Words
Spam detected?
Headings
Heading distribution
Heading normalisation
Heading SEO impact
Emphasis (bold and italic)
Emphasis SEO impact
Images
Number of images
Images dimensions
Image alt descriptions
Images SEO impact
wikipedia free encyclopedia check edit wikidata icon wikimedia foundation powered mediawiki
Mobile SEO en.wikipedia.org/wiki/filgotinib
Mobile rendering
Mobile optimizations
Responsive design detected (mobile css)
No flash detected !
Mobile improvement
Marketing / lead generation for en.wikipedia.org/wiki/filgotinib
Social Media
Facebook shares | Facebook likes | ||
Facebook comments | Tweets | ||
Google +1 |
Conversion form
Search form
Analytics
Online presence
SERP Preview
SERP Title
SERP Link
SERP Description
Domain Level SEO
Domain name
16 characters long
Domain name SEO Impact
Path name
filgotinib found in path !
Structured data
Publisher Markup
Other Structured data
Website configuration
Correct processing of non-existing pages?
Favicon icon found?
Robots.txt found?
Sitemap found?
Navigation and internal links
Navigation
Url seperator
Human readable urls
Number of links
Link SEO Impact
statistics
|
en.m.wikipedia.org |
en.wikipedia.org wikimedia foundation inc
|
w view history
httpsenwikipediaorgwindexphptitlefilgotiniboldid1218410315
page information
printable version
asialo erythropoietin
carbamylated erythropoietin
epoetin delta
epoetin epsilon
epoetin gamma
epoetin kappa
epoetin omega
erythropoietinfc
pegol sihematide epo018b
nartograstim
pegnartograstim
ecogramostim
pegacaristim
interferon alfa n1
cercosporamide
|
wiki read
trade names
legal status
european medicines agency
routes ofadministration
by mouth
drug class
inhibitors
l04
pharmacokinetics
elimination halflife
iupac name
cas number
pubchem
iupharbps
drugbank
chemspider
kegg
chembl
pdb ligand
comptox dashboard
formula
molar mass
jsmol
rheumatoid arthritis
belgian
dutch
galapagos nv
indicated
methotrexate
jak1
upadacitinib
tofacitinib tasocitinib
baricitinib
proinflammatory
cytokines
anemia
thrombopenia
erythropoietin epo
thrombopoietin thpo mgdf
granulocytemacrophage colonystimulating factor
new drug application
priority review
food and drug administration
committee for medicinal products for human use
phase iib program
cyp450
carboxylesterases
acr20 score
double blind
placebocontrolled
adalimumab
gilead sciences
pmid
clinicaltrialsgov
immunosuppressive drugs
immunosuppressants
antimetabolites
purine synthesis inhibitors
azathioprine
mycophenolic acid
dihydroorotate dehydrogenase
leflunomide
teriflunomide
antifolate
macrolides
il2
fkbp
cyclophilin
calcineurin
ciclosporin
pimecrolimus
tacrolimus
voclosporin
abetimus
gusperimus
lenalidomide
pomalidomide
thalidomide
pde4 inhibitor
apremilast
il1 receptor antagonists
anakinra
mtor
sirolimus
everolimus
ridaforolimus
temsirolimus
umirolimus
zotarolimus
antibodies
monoclonal
complement component 5
eculizumab
tnf inhibitor
afelimomab
certolizumab pegol
golimumab
infliximab
nerelimomab
interleukin
basiliximab
bimekizumab
briakinumab
brodalumab
canakinumab
daclizumab
guselkumab
ixekizumab
olokizumab
rilonacept
risankizumab
sarilumab
satralizumab
secukinumab
siltuximab
sirukumab
spesolimab
tildrakizumab
tocilizumab
ustekinumab
interleukin 5
mepolizumab
immunoglobulin e
omalizumab
interferon
faralimomab
il6
elsilimomab
il12
il23
lebrikizumab
il17a
muromonabcd3
otelixizumab
teplizumab
visilizumab
cd4
clenoliximab
keliximab
zanolimumab
cd11a
efalizumab
cd18
erlizumab
cd20
obinutuzumab
ocrelizumab
pascolizumab
rituximab
ublituximab
cd23
gomiliximab
lumiliximab
cd40
teneliximab
toralizumab
cd62llselectin
aselizumab
cd80
galiximab
cd147basigin
gavilimomab
cd154
ruplizumab
frexalimab
belimumab
bertilimumab
lerdelimumab
metelimumab
integrin
natalizumab
vedolizumab
interleukin6 receptor
odulimomab
il2 receptorcd25
inolimomab
tlymphocyte
zolimomab aritox
alemtuzumab
anifrolumab
atorolimumab
cedelizumab
emapalumab
fontolizumab
inebilizumab
maslimomab
morolimumab
ofatumumab
pexelizumab
reslizumab
rovelizumab
siplizumab
talizumab
telimomab aritox
teprotumumab
vapaliximab
vepalimomab
polyclonal
antithymocyte globulin
antilymphocyte globulin
fusion protein
ctla4
abatacept
belatacept
etanercept
aflibercept
alefacept
avacopan
blisibimod
crovalimab
danicopan
deucravacitinib
efgartigimod alfa
hyaluronidase
etrasimod
fingolimod
iptacopan
ozanimod
peficitinib
pegcetacoplan
ponesimod
ravulizumab
ritlecitinib
rozanolixizumab
siponimod
sutimlimab
targeted cancer therapy
antineoplastic agents
l01
monoclonal antibodies
receptor tyrosine kinase
erbb
her1egfr
cetuximab
panitumumab
her2neu
pertuzumab
trastuzumab
hyaluronidase
trastuzumab emtansine
trastuzumab deruxtecan
epcam
catumaxomab
edrecolomab
bevacizumab
leukemia
lymphoma
lymphoid
glofitamab
elranatamab
mosunetuzumab
ibritumomab
tositumomab
cd30
brentuximab
cd52
myeloid
cd33
gemtuzumab ozogamicin
amivantamab
atezolizumab
avelumab
belantamab mafodotin
bermekimab
blinatumomab
cemiplimab
daratumumab
dinutuximab beta
dostarlimab
durvalumab
elotuzumab
enfortumab vedotin
epcoritamab
inotuzumab ozogamicin
ipilimumab
isatuximab
loncastuximab tesirine
mirvetuximab soravtansine
mogamulizumab
moxetumomab pasudotox
naxitamab
necitumumab
nivolumab
olaratumab
oportuzumab monatox
pembrolizumab
polatuzumab vedotin
ramucirumab
retifanlimab
sacituzumab govitecan
sugemalimab
tafasitamab
talquetamab
tarlatamab
teclistamab
tislelizumab
tisotumab vedotin
toripalimab
tremelimumab
tyrosine kinase inhibitors
afatinib
brigatinib
dacomitinib
erlotinib
gefitinib
icotinib
mobocertinib
olmutinib
osimertinib
rociletinib
vandetanib
lapatinib
neratinib
tucatinib
rtk class iii
scf ckit
avapritinib
axitinib
masitinib
pazopanib
ripretinib
sorafenib
sunitinib
toceranib
flt3
lestaurtinib
gilteritinib
vegfr
cediranib
fruquintinib
lenvatinib
nintedanib
regorafenib
semaxanib
tivozanib
alectinib
ceritinib
entrectinib
futibatinib
infigratinib
larotrectinib
pemigatinib
pralsetinib
repotrectinib
selpercatinib
cmet
cabozantinib
capmatinib
crizotinib
nonreceptor
bcrabl
asciminib
bosutinib
dasatinib
imatinib
nilotinib
ponatinib
radotinib
src
jak
fedratinib
momelotinib
pacritinib
ruxolitinib
binimetinib
cobimetinib
selumetinib
trametinib
eml4
lorlatinib
brutons
acalabrutinib
ibrutinib
pirtobrutinib
zanubrutinib
proapoptotic
anxa2
prohibitin
adipotide
exotoxin
denileukin diftitox
mtor inhibitors
hedgehog
glasdegib
sonidegib
vismodegib
cdk inhibitors
abemaciclib
dalpiciclib
palbociclib
ribociclib
trilaciclib
kras
adagrasib
sotorasib
erdafitinib
midostaurin
pexidartinib
quizartinib
tebentafusp
tepotinib
venetoclax
cytokine receptor
modulators
chemokine
erythropoietin
darbepoetin alfa
epoetin alfa
epoetin beta
epoetin theta
epoetin zeta
methoxy polyethylene glycolepoetin beta ceramircera
peginesatide
filgrastim
granulocyte colonystimulating factor
lenograstim
lipegfilgrastim
pegfilgrastim
granulocyte macrophage colonystimulating factor
molgramostim
sargramostim
mavrilimumab
namilumab
otilimab
interleukin34
macrophage colonystimulating factor
thrombopoietin
eltrombopag
promegapoietin
romiplostim
interferon
ifnar i
albinterferon
interferon alpha interferon alfa ifn
interferon alfa
ifna1
ifna2
ifna4
ifna5
ifna6
ifna7
ifna8
ifna10
ifna13
ifna14
ifna16
ifna17
ifna21
interferon alfa 2a
interferon alfa 2b
interferon alfacon1
interferon alphan3
interferon beta ifn
ifnb1
interferon beta 1a
interferon beta 1b
interferon kappa ifn ifnk
interferon omega ifn ifnw1
peginterferon alfa2a
peginterferon alfa2b
rontalizumab
sifalimumab
ifngr ii
interferon gamma ifn
interferon gamma 1b
ifnlr iii
interleukin
abrocitinib
oclacitinib
jak2
atiprimod
chz868
cucurbitacin i elatericin b jsi124
cyt387
jak3
decernotinib vx509
tyk2
cardiotrophin 1 ct1
fmslike tyrosine kinase 3 ligand flt3l
leukemialeukocyte inhibitory factor lif
oncostatin m osm
thymic stromal lymphopoietin tslp
|
Links to external pages
Outloing links
ja.wikipedia.org
www.wikidata.org
www.wikidata.org
commons.wikimedia.org
www.ema.europa.eu
commonchemistry.cas.org
pubchem.ncbi.nlm.nih.gov
www.guidetopharmacology.org
www.drugbank.ca
www.chemspider.com
precision.fda.gov
www.kegg.jp
www.kegg.jp
www.ebi.ac.uk
www.ebi.ac.uk
www.rcsb.org
comptox.epa.gov
www.wikidata.org
chemapps.stolaf.edu
www.medicines.org.uk
ec.europa.eu
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.businesswire.com
pubmed.ncbi.nlm.nih.gov
web.archive.org
ml-eu.globenewswire.com
www.glpg.com
web.archive.org
www.globenewswire.com
pubmed.ncbi.nlm.nih.gov
web.archive.org
reports.glpg.com
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.clinicaltrials.gov
www.fiercebiotech.com
www.clinicaltrials.gov
www.clinicaltrials.gov
www.clinicaltrials.gov
www.clinicaltrials.gov
www.clinicaltrials.gov
www.clinicaltrials.gov
www.clinicaltrials.gov
foundation.wikimedia.org
foundation.wikimedia.org
foundation.wikimedia.org
www.wikimediafoundation.org
SEO Advice for en.wikipedia.org
In this section we provide pointers on how you can to optimize your web page so it can be found more easily by search engines and how to make it rank higher by optimizing the content of the page itself. For each of the individual criteria the maximum score is 100%. A score below 70% is considered to be indication that the page is not complying with general SEO standards and should be evaluated and/or fixed. Not every factor is weighted the same and some are not as important as others. Relatively unimportant factors like meta keywords are not included in the overall score.
Item | Factor | Pointers | |
---|---|---|---|
PageTitle | 100% | Far too many sites lack a page title. A page title is the first thing that shows in the search results so always use the title element. | |
Title relevance | 65% | A title should reflect the contents of a site. This site has a 50 % match | |
Title Length | 30% | Limit your title to anywhere between 40 and 70 characters. Your title was 23 characters long | |
Meta Description | 0% | A meta description is the second element that shows in the search results so always use the meta description. | |
Meta description length | 0% | The meta description should be between 145 and 160 characters. This meta description is 1 characters long. | |
Meta description relevance | 0% | Meta Description should reflect the contents of a site. This site has a 0 % match | |
Number of internal links | 30% | Linking to internal pages makes pages easier to find for search engines. Try to keep the number of links on your page roughly below 100. There are 716 internal links on this page. | |
Folder structure | 100% | We found a folder structure in the links on your page. A good folder structure makes a site easier to navigate. We found 3 level 1 folders and 10 folders above or in the first level of navigation. | |
Headings | 76% | Headers should reflect the contents of a site. This site has a 33 % match | |
Links | 8% | Link anchors should to some degree reflect the contents of a site. This site has a 4 % match | |
Image alt tags | 25% | Image alt tags should to some degree reflect the contents of a site. This site has a 9 % match | |
Bold and italic | 33% | Bold and italic tags should reflect the contents of a site to some degree. This site has a 11 % match | |
Html ratio | 40% | Try to keep the html / text ratio as low as possible. More html means longer loading times. Layout should be handled in a serpate css file | |
Image descriptions | 80% | 80 % of all images have been described via the "alt" attribute. Describing images with relevant text may lead to better results in the search engines. | |
Page errors | 100% | Pages with no errors display significantly faster on most browsers. We detected 0 errors and warnings | |
WordCount | 20% | An ideal page contains between 400 and 600 words.This page contains 3392 words | |
Server response time | 30% | A slow server slows down a website. This server responds 168.8% slower the average | |
Gzip compression | 30% | This site does not use Gzip compression. Pages may not display as fast as they could | |
Keywords in Domainname | 30% | There are no important keywords in your domain name | |
Keywords in domain path | 100% | There are important keywords in the domain path | |
Structured Data | 100% | Structured data makes it easier for search engines to index your website | |
Inline css | 0% | Do not use inline css declarations. Inline css will slow down the rendering of the website. We detected 243 inline style declarations ( <a style="color:green">) with a size of 5109 bytes | |
Excessive use of the same words | 100% | There is no indication that there are one or more keywords that are used excessively. | |
Frames or iframes | 100% | Perfect, detected not (i)frames on your webpagina | |
Flash | 100% | Perfect, we detected no flash objects on your page | |
Css | 30% | We detected too much (2) CSS files on your page. Css files block the loading of a webpage. | |
Javascript | 100% | Perfect, we did not detect too many blocking JavaScript files | |
Mobile Website | 100% | Perfect, we found a responsive design for mobile users | |
Most important heading | 100% | Perfect, we detected a correct use of the most important (h1) heading! | |
Normalized headings | 40% | We dit not font a normalized heading structure. A heading 2 (h2) for example should be followed by a heading of an equal level (h2), a child heading (h3) or even a aprent heading (h1). |
How would you like to have SEO advice for all your pages ?? Start your SEO Dashboard and optimize your website!
en.wikipedia.org images and descriptions
12 images found at en.wikipedia.org Images can improve the user experience for a website by making a pag visually appealing Images can also add extra keyword relevance to a webpage by using alt tags. Images can also slow down a website. If the width and height for a picture is not specified for a browser know in advance how large the image is. A browser must first load the picture and see before it knows how much space should be on the page. Upon reservation In the meantime, the browser can do little but wait. When the height and width for the plate are given in the HTML code, a browser just continues to build for a page while the images load in the background.
http://en.wikipedia.org/static/images/icons/wikipedia.png height: 50 width: 50 description: no alt description found |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-wordmark-en.svg height: height attribute not set width: width attribute not set description: wikipedia |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-tagline-en.svg height: 13 width: 117 description: the free encyclopedia |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/9/90/filgotinib.svg/220px-filgotinib.svg.png height: 157 width: 220 description: no alt description found |
|
https://upload.wikimedia.org/wikipedia/en/thumb/f/fb/yes_check.svg/7px-yes_check.svg.png height: 7 width: 7 description: check |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/x_mark.svg/7px-x_mark.svg.png height: 8 width: 7 description: ☒ |
|
https://upload.wikimedia.org/wikipedia/en/thumb/8/8a/oojs_ui_icon_edit-ltr-progressive.svg/10px-oojs_ui_icon_edit-ltr-progressive.svg.png height: 10 width: 10 description: edit this at wikidata |
|
https://upload.wikimedia.org/wikipedia/en/thumb/4/4a/commons-logo.svg/12px-commons-logo.svg.png height: 16 width: 12 description: no alt description found |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/who_rod.svg/8px-who_rod.svg.png height: 19 width: 8 description: icon |
|
https://login.wikimedia.org/wiki/special:centralautologin/start?type=1x1 height: 1 width: 1 description: no alt description found |
|
http://en.wikipedia.org/static/images/footer/wikimedia-button.png height: 31 width: 88 description: wikimedia foundation |
|
http://en.wikipedia.org/static/images/footer/poweredby_mediawiki_88x31.png height: 31 width: 88 description: powered by mediawiki |
How are images contributing to your SEO site-wise ? Your leading content tool has the awnsers!